Review decisions
Showing 540 results of 1549 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00979
Product Type: Drug
Control Number: 254352
DIN(s): 02529254
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-07-02
Decision / Authorization Date: 2022-07-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00969
Product Type: Drug
Control Number: 263775
Manufacturer: ModernaTX, Inc.
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2022-04-29
Decision / Authorization Date: 2022-07-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01019
Product Type: Drug
Control Number: 240368
Manufacturer: Kye Pharmaceuticals Inc., Canada
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2020-12-18
Decision / Authorization Date: 2022-07-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01061
Product Type: Drug
Control Number: 254495
DIN(s): 02528908
Manufacturer: Merck Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-07-09
Decision / Authorization Date: 2022-07-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00973
Product Type: Drug
Control Number: 259725
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-20
Decision / Authorization Date: 2022-07-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00971
Product Type: Drug
Control Number: 259703
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-17
Decision / Authorization Date: 2022-07-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01102
Product Type: Drug
Control Number: 245854
DIN(s): 02528363, 02528371, 02528398
Manufacturer: Pfizer Canada ULC., on behalf of BioNTech Manufacturing GmbH
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2020-10-29
Decision / Authorization Date: 2022-06-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01056
Product Type: Drug
Control Number: 253652
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-06-10
Decision / Authorization Date: 2022-06-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01060
Product Type: Drug
Control Number: 255700
DIN(s): 02528320, 02528339
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-08-13
Decision / Authorization Date: 2022-06-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01092
Product Type: Drug
Control Number: 225901
DIN(s): 02528096
Manufacturer: Taro Pharmaceuticals Inc.
Submission Type: Abbreviated New Drug Submission
Date Filed / Submission Date: 2019-04-30
Decision / Authorization Date: 2022-06-21